Mesenchymal Stem-Cell Immunosuppressive Capabilities: Therapeutic Implications in Islet Transplantation
Authors:
- 15 February 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 89 (3) , 270-273
Abstract
Mesenchymal stem cells (MSCs) are known to be capable of suppressing immune responses and offer therapeutic potential for achieving transplantation tolerance. This review will discuss the impacts of MSCs on transplant immunity and focus on the potential role of MSCs in protecting islet grafts from both rejection and autoimmune attack.Keywords
This publication has 26 references indexed in Scilit:
- Mesenchymal Stem Cells: A Potential Border Patrol for Transplanted Islets?Diabetes, 2009
- Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolateTransplant Immunology, 2008
- Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell TransplantationPLOS ONE, 2008
- IFN‐γ activation of mesenchymal stem cells for treatment and prevention of graft versus host diseaseEuropean Journal of Immunology, 2008
- International Trial of the Edmonton Protocol for Islet TransplantationNew England Journal of Medicine, 2006
- Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative settingBlood, 2006
- Bone Marrow Mesenchymal Stem Cells Suppress Lymphocyte Proliferation In Vitro but Fail to Prevent Graft-versus-Host Disease in MiceThe Journal of Immunology, 2006
- Human mesenchymal stem cells modulate B-cell functionsBlood, 2006
- Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cellsThe Lancet, 2004
- Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivoExperimental Hematology, 2002